Q3 2021 TFF Pharmaceuticals Inc Earnings Call Transcript
Greetings, ladies and gentlemen, and thank you for standing by. Welcome to the TFF Pharmaceuticals Third Quarter 2021 Results Conference Call. As a reminder, this conference call is being recorded. (Operator Instructions)
I would now like to introduce Corey Davis of LifeSci Advisors to begin the call.
Thank you, operator. Hello, everyone, and welcome to the TFF Pharmaceuticals' Third Quarter 2021 Financial and Business Results Conference Call. With me on the line today is Glenn Mattes, President and CEO of TFF; Kirk Coleman, Chief Financial Officer; Dr. Dale Christensen, TFF Director of Clinical Development; and Dr. Bill Williams of the University of Texas at Austin; Chris Cano, TFF's Chief Operating Officer. The press release announcing our third quarter results is available on the TFF Pharmaceuticals website.
Please take a moment to read the disclaimer about forward-looking statements in the release. This earnings release and this teleconference both include forward-looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |